RxAnte Inc.
Predictive medication adherence analytic solutions
This article was originally published in Start Up
Executive Summary
A team of public health and clinical outcomes experts has developed a suite of analytic software tools to predict – they claim as early as the first time a patient takes a new medicine – which patients will likely need interventions to remain adherent and to recommend interventions that will improve adherence as efficiently as possible. These experts launched RxAnte Inc. to commercialize their data analytics solution that enables users to analyze large data sets and drill down from the population level to the individual patient level. They hope to increase the clinical outcomes and economic returns from effective interventions by “fitting” them to the right patients at the right time.